Martin C. Michel
Martin C. Michel is a physician trained in experimental and clinical pharmacology in Essen (Germany) and San Diego (California). He headed the Nephrology and Hypertension Research Laboratory at the University of Essen (Germany; 1993-2002), the Department of Pharmacology & Pharmacotherapy at the University of Amsterdam (The Netherlands; 2003-2011) and was Global Head of Product and Pipeline Scientific Support at Boehringer Ingelheim (Germany; 2011-2016). His current affiliations include being a Professor of Pharmacology at the Johannes Gutenberg University in Mainz (Germany; since 2012) and being a Senior Partner at the Partnership for the Assessment and Accreditation of Science (PAASP, Heidelberg, Germany; since 2016). His research focusses on urogenital and cardiovascular pharmacology, where he has published more than 500 peer-reviewed articles cited >28,000 times. He is editor or serves on the board of many pharmacological journals including Mol Pharmacol and Pharmacol Rev.